Trial Profile
Phase Ia trial of OTX 015 in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Dec 2012
Price :
$35
*
At a glance
- Drugs Birabresib (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 06 Dec 2012 New trial record